Federated Drug Design
The activities of Qubigen are focused on better protecting your data during the drug design process. Qubigen can help draw insights from molecular and biological data without moving or even seeing the data, avoiding any risk of exposing sensitive intellectual property.
By combining Federated AI with molecular mechanics and quantum chemistry, Qubigen can help design novel medicines that a single company might not have been able to develop on their own.
01
Project Selection
Qubigen can assist pharmaceutical companies shorten the drug development process, saving time and money by generating better quality candidates, faster. Ask us how we can help you make the best use of your valuable data, at enquiries@qubigen.com.
Our Data Access Partners have the opportunity to participate in collaborative projects to help design novel medicines that no single company could develop on their own.
​
02
Federated AI
Qubigen can securely draw key insights from protected data to design novel molecular structures using our unique infrastructure based on Federated Learning.
03
Molecule Generation
Qubigen draws on its unique infrastructure and computational tools to generate high quality drug candidates for specific protein targets.
04
Virtual Screening & Quantum Chemistry
Qubigen uses a unique combination of algorithms to assess and screen novel compounds, based on molecular mechanics and quantum chemistry.
